Effect of upfront combination therapy on the overall survival of patients with metastatic castration‐sensitive prostate cancer: A multicenter retrospective study-Reference-Cited by-同舟云学术

Effect of upfront combination therapy on the overall survival of patients with metastatic castration‐sensitive prostate cancer: A multicenter retrospective study

Published:2022-02-07 Issue:5 Volume:29 Page:476-478
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int J of Urology

Author:

Tanaka Toshikazu¹,Hatakeyama Shingo²^ORCID,Noro Daisuke³,Togashi Kyo⁴,Yoneyama Takahiro⁵,Ohyama Chikara²⁴⁵

Affiliation:

1. Department of Urology Aomori Prefectural Central Hospital Aomori Japan

2. Department of Advanced Blood Purification Therapy Hirosaki University Graduate School of Medicine Hirosaki Japan

3. Department of Urology Mutsu General Hospital Mutsu Japan

4. Departments of Urology Hirosaki University Graduate School of Medicine Hirosaki Japan

5. Department of Advanced Transplant and Regenerative Medicine Hirosaki University Graduate School of Medicine Hirosaki Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/iju.14817

Reference6 articles.

1. Systemic therapies for metastatic hormone‐sensitive prostate cancer: network meta‐analysis

2. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial

3. Abiraterone acetate plus prednisone in patients with newly diagnosed high-risk metastatic castration-sensitive prostate cancer (LATITUDE): final overall survival analysis of a randomised, double-blind, phase 3 trial

4. Indirect Comparisons of Efficacy between Combination Approaches in Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Network Meta-analysis

5. Comparison of Systemic Treatments for Metastatic Castration-Sensitive Prostate Cancer

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enzalutamide Prolonged the Duration of Drug Use in Comparison to Abiraterone Acetate and Cabazitaxel after Upfront Docetaxel: A Large Japanese Database Study;Diseases;2024-07-18

2. Clinical Outcomes of Patients with High-risk Metastatic Hormone-naïve Prostate Cancer: A 3-year Interim Analysis of the Observational J-ROCK Study;European Urology Oncology;2024-06

3. Prognostic outcomes in Japanese patients with metastatic castration‐sensitive prostate cancer: Comparative assessments between conventional androgen deprivation therapy (ADT) and ADT with novel androgen receptor signal inhibitor;International Journal of Urology;2024-05-19

4. The Geriatric Nutritional Risk Index Predicts Prognosis in Japanese Patients with LATITUDE High-Risk Metastatic Hormone-Sensitive Prostate Cancer: A Multi-Center Study;Cancers;2023-11-08

5. Effects of apalutamide dose reduction on skin‐related adverse events in patients with advanced prostate cancer: A multicenter retrospective study;The Prostate;2022-10-31